DAUNORUBICIN HYDROCHLORIDE

DAUNORUBICIN HYDROCHLORIDE was reported 1648 times

DAUNORUBICIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERMITTENT POSITIVE PRESSURE BREATHING 6 0.4286
1 LYMPHOID TISSUE HYPOPLASIA 65 0.4248
2 THYMUS HYPOPLASIA 67 0.3851
3 HUMAN BOCAVIRUS INFECTION 44 0.2328
4 GALLBLADDER FIBROSIS 2 0.2000
5 BRAIN SARCOMA 6 0.2000
6 GRANULICATELLA INFECTION 7 0.1667
7 ACQUIRED ANTITHROMBIN III DEFICIENCY 2 0.1429
8 FOETAL ANAEMIA 18 0.1374
9 GLUTATHIONE SYNTHETASE DEFICIENCY 3 0.1304
10 SECONDARY IMMUNODEFICIENCY 130 0.1070
11 ABORTED PREGNANCY 5 0.1064
12 LEUKOERYTHROBLASTOSIS 10 0.1000
13 RETINITIS VIRAL 12 0.0992
14 DISSEMINATED ASPERGILLOSIS 41 0.0869
15 CYSTITIS BACTERIAL 27 0.0799
16 PERICORONITIS 7 0.0769
17 GENE MUTATION IDENTIFICATION TEST NEGATIVE 1 0.0769
18 GASTROSPLENIC FISTULA 3 0.0714
19 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 16 0.0690
20 NOROVIRUS TEST POSITIVE 22 0.0677
21 MYCOBACTERIUM CHELONAE INFECTION 50 0.0677
22 CHOLANGITIS CHRONIC 3 0.0667
23 PROTEIN C INCREASED 5 0.0633
24 ANTI-HLA ANTIBODY TEST POSITIVE 1 0.0588
25 PLEUROPARENCHYMAL FIBROELASTOSIS 5 0.0481
26 CEREBELLAR TUMOUR 6 0.0476
27 CANDIDA ENDOPHTHALMITIS 5 0.0410
28 T-CELL TYPE ACUTE LEUKAEMIA 8 0.0392
29 PORTAL VEIN EMBOLISM 1 0.0385
30 CORONA VIRUS INFECTION 16 0.0372
31 CEREBELLAR EMBOLISM 1 0.0345
32 PSEUDOMONAL SEPSIS 58 0.0331
33 PERIVENTRICULAR LEUKOMALACIA 9 0.0318
34 HUMAN HERPESVIRUS 6 INFECTION 58 0.0307
35 CONGENITAL APLASIA 9 0.0289
36 LOWER RESPIRATORY TRACT INFECTION FUNGAL 11 0.0283
37 ENCEPHALITIC INFECTION 1 0.0270
38 PARAINFLUENZAE VIRUS INFECTION 41 0.0269
39 ACUTE MYELOID LEUKAEMIA RECURRENT 55 0.0256
40 ENTEROBACTER INFECTION 42 0.0250
41 ABSCESS BACTERIAL 9 0.0248
42 CAECITIS 11 0.0244
43 RESTRICTIVE CARDIOMYOPATHY 7 0.0231
44 FLAVOBACTERIUM INFECTION 1 0.0227
45 GASTROENTERITIS NOROVIRUS 29 0.0218
46 CSF GLUCOSE INCREASED 2 0.0208
47 MEDIASTINAL HAEMORRHAGE 2 0.0206
48 POSITIVE AIRWAY PRESSURE THERAPY 6 0.0205
49 NEURILEMMOMA 1 0.0204
50 ENCEPHALITIS BACTERIAL 1 0.0196
51 WHITE MATTER LESION 24 0.0190
52 BLOOD FIBRINOGEN DECREASED 20 0.0175
53 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 4 0.0174
54 STENOTROPHOMONAS SEPSIS 2 0.0165
55 ANORECTAL CELLULITIS 1 0.0164
56 ACTIVATED PARTIAL THROMBOPLASTIN TIME 1 0.0164
57 MYELOID LEUKAEMIA 8 0.0160
58 PNEUMATOSIS INTESTINALIS 45 0.0158
59 CYTOMEGALOVIRUS VIRAEMIA 70 0.0157
60 ANTITHROMBIN III DECREASED 4 0.0147
61 VIRAEMIA 20 0.0144
62 PARESIS CRANIAL NERVE 1 0.0143
63 CEREBRAL TOXOPLASMOSIS 13 0.0139
64 DIFFUSE ALVEOLAR DAMAGE 16 0.0139
65 PNEUMOCYSTIS TEST POSITIVE 1 0.0139
66 MONONUCLEAR CELL COUNT ABNORMAL 1 0.0137
67 CYTARABINE SYNDROME 1 0.0132
68 PANTOEA AGGLOMERANS INFECTION 1 0.0130
69 DACRYOCYSTITIS 2 0.0130
70 PERIORBITAL INFECTION 1 0.0123
71 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 1 0.0123
72 CYTOMEGALOVIRUS CHORIORETINITIS 24 0.0123
73 PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0123
74 ACUTE MYELOID LEUKAEMIA REFRACTORY 2 0.0116
75 HYPERHOMOCYSTEINAEMIA 3 0.0115
76 SYSTEMIC MYCOSIS 13 0.0111
77 RHINOVIRUS INFECTION 43 0.0110
78 CLOSTRIDIUM DIFFICILE COLITIS 115 0.0108
79 CAPNOCYTOPHAGA INFECTION 1 0.0106
80 PROTOTHECOSIS 1 0.0106
81 CEREBRAL FUNGAL INFECTION 3 0.0106
82 CEREBRAL SALT-WASTING SYNDROME 1 0.0101
83 HYPOFIBRINOGENAEMIA 10 0.0101
84 PALATAL ULCER 1 0.0094
85 KARYOTYPE ANALYSIS ABNORMAL 1 0.0092
86 DELIVERY 6 0.0091
87 MALIGNANT MEDIASTINAL NEOPLASM 1 0.0091
88 CENTRAL HYPOTHYROIDISM 3 0.0091
89 VENOUS THROMBOSIS 35 0.0089
90 BRONCHOPULMONARY ASPERGILLOSIS 69 0.0089
91 SCLERAL HAEMORRHAGE 2 0.0087
92 BONE MARROW NECROSIS 2 0.0085
93 BACTERIAL INFECTION 158 0.0085
94 COPPER DEFICIENCY 1 0.0083
95 DYSPLASIA 10 0.0083
96 INCARCERATED INGUINAL HERNIA 1 0.0082
97 HERPES SIMPLEX VIRAEMIA 1 0.0080
98 ANAL ERYTHEMA 1 0.0080
99 INFECTION REACTIVATION 9 0.0079
100 BALANITIS CANDIDA 1 0.0078
101 PROSTATIC CALCIFICATION 1 0.0078
102 BACTERIAL TOXAEMIA 1 0.0078
103 CARDIAC VENTRICULAR THROMBOSIS 10 0.0077
104 BACTERIA BLOOD IDENTIFIED 1 0.0076
105 SKIN TOXICITY 43 0.0076
106 OEDEMATOUS KIDNEY 2 0.0075
107 PERICARDITIS INFECTIVE 1 0.0072
108 ENTERITIS 46 0.0072
109 URETERITIS 2 0.0071
110 METASTASES TO PANCREAS 3 0.0068
111 NEUTROPENIC COLITIS 14 0.0068
112 PROTEIN S DECREASED 1 0.0068
113 ASPERGILLUS INFECTION 43 0.0065
114 PRIMARY HYPOGONADISM 1 0.0064
115 HAEMOSTASIS 1 0.0061
116 PAROTID GLAND ENLARGEMENT 4 0.0061
117 LACTOBACILLUS INFECTION 1 0.0061
118 MEDIASTINUM NEOPLASM 1 0.0060
119 OESOPHAGEAL CANDIDIASIS 24 0.0060
120 INFECTIVE MYOSITIS 1 0.0060
121 GRANULOCYTE COUNT DECREASED 11 0.0059
122 CARBON MONOXIDE DIFFUSING CAPACITY DECREASED 1 0.0059
123 COMPUTERISED TOMOGRAM THORAX ABNORMAL 4 0.0058
124 BLOOD LACTIC ACID DECREASED 1 0.0058
125 POSTURING 3 0.0058
126 FUNGAEMIA 9 0.0057
127 ABSCESS FUNGAL 1 0.0057
128 BASOPHIL PERCENTAGE INCREASED 1 0.0057
129 BASE EXCESS DECREASED 1 0.0056
130 CONJUNCTIVAL PALLOR 1 0.0055
131 HEART TRANSPLANT 5 0.0055
132 STREPTOCOCCAL BACTERAEMIA 6 0.0055
133 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 14 0.0054
134 LARYNGEAL INFLAMMATION 1 0.0053
135 LEUKAEMIA RECURRENT 9 0.0053
136 PNEUMONIA FUNGAL 21 0.0053
137 MYELOSUPPRESSION 187 0.0052
138 STENOTROPHOMONAS INFECTION 7 0.0052
139 ATONIC URINARY BLADDER 1 0.0052
140 CHRONIC PIGMENTED PURPURA 1 0.0051
141 GRANULOCYTOSIS 1 0.0051
142 GENE MUTATION 10 0.0050
143 CD8 LYMPHOCYTES DECREASED 1 0.0050
144 HUMAN HERPESVIRUS 8 INFECTION 3 0.0049
145 TUMOUR ASSOCIATED FEVER 2 0.0049
146 VENOOCCLUSIVE LIVER DISEASE 24 0.0049
147 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
148 TRANSPLANTATION COMPLICATION 2 0.0048
149 GEOTRICHUM INFECTION 1 0.0047
150 GLIOMA 3 0.0047
151 TOXOPLASMOSIS 5 0.0046
152 HYPERTRIGLYCERIDAEMIA 27 0.0046
153 PARALYSIS FLACCID 1 0.0046
154 CONGESTIVE HEPATOPATHY 2 0.0045
155 PROTEUS TEST POSITIVE 1 0.0045
156 LYMPHOPENIA 63 0.0044
157 SARS-COV-2 TEST NEGATIVE 3 0.0044
158 ENTEROCOLITIS INFECTIOUS 4 0.0043
159 NECROTISING SOFT TISSUE INFECTION 1 0.0043
160 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0043
161 HERPES SIMPLEX 28 0.0043
162 CEREBRAL MICROANGIOPATHY 1 0.0042
163 JEJUNAL PERFORATION 1 0.0041
164 CLOSTRIDIAL SEPSIS 1 0.0041
165 DIFFERENTIATION SYNDROME 3 0.0041
166 DEVICE RELATED THROMBOSIS 4 0.0041
167 CHRONIC SINUSITIS 15 0.0040
168 ACUTE MYELOMONOCYTIC LEUKAEMIA 1 0.0040
169 ERYTHEMA INFECTIOSUM 1 0.0039
170 PHARYNGITIS BACTERIAL 1 0.0039
171 HEPATIC TRAUMA 1 0.0039
172 ESCHERICHIA PYELONEPHRITIS 1 0.0039
173 INTESTINAL SEPSIS 1 0.0038
174 ENTEROCOCCAL INFECTION 18 0.0037
175 VASCULAR ACCESS COMPLICATION 3 0.0037
176 PALPABLE PURPURA 1 0.0036
177 VENOOCCLUSIVE DISEASE 9 0.0036
178 APLASIA 7 0.0036
179 OEDEMATOUS PANCREATITIS 2 0.0036
180 GENITOURINARY TRACT INFECTION 1 0.0035
181 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 1 0.0034
182 PNEUMONIA INFLUENZAL 4 0.0034
183 VITRECTOMY 2 0.0034
184 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
185 HYPOALBUMINAEMIA 26 0.0033
186 LUNG INJURY 1 0.0033
187 MUCOSAL EROSION 3 0.0033
188 ASPERGILLUS TEST POSITIVE 1 0.0032
189 DEVICE RELATED BACTERAEMIA 1 0.0032
190 ENCEPHALITIS 22 0.0032
191 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
192 FEBRILE NEUTROPENIA 205 0.0031
193 ENTEROCOCCUS TEST POSITIVE 2 0.0031
194 DRUG CLEARANCE DECREASED 4 0.0031
195 ACQUIRED GENE MUTATION 4 0.0031
196 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 2 0.0030
197 BONE MARROW FAILURE 62 0.0030
198 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
199 LEUKOENCEPHALOPATHY 11 0.0030
200 VARICELLA ZOSTER VIRUS INFECTION 6 0.0029
201 POLYMERASE CHAIN REACTION POSITIVE 1 0.0029
202 FUSARIUM INFECTION 2 0.0029
203 HYPERPYREXIA 12 0.0028
204 SYSTEMIC CANDIDA 7 0.0028
205 INFECTION IN AN IMMUNOCOMPROMISED HOST 2 0.0028
206 SECOND PRIMARY MALIGNANCY 23 0.0028
207 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 1 0.0028
208 CEREBRAL VENOUS THROMBOSIS 5 0.0028
209 GASTRIC MUCOSAL LESION 2 0.0027
210 FUNGAL INFECTION 91 0.0027
211 CACHEXIA 14 0.0027
212 AXILLARY VEIN THROMBOSIS 1 0.0027
213 COMA HEPATIC 2 0.0027
214 ALKALOSIS 1 0.0026
215 CYSTITIS VIRAL 1 0.0026
216 INTRACARDIAC THROMBUS 8 0.0026
217 CALCULUS URINARY 4 0.0026
218 VIRAL INFECTION 86 0.0026
219 PANCREATIC PSEUDOCYST 2 0.0026
220 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
221 HYDROCEPHALUS 14 0.0026
222 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 2 0.0026
223 FEBRILE INFECTION 3 0.0025
224 EYE INFECTION TOXOPLASMAL 1 0.0025
225 CATHETER SITE EXTRAVASATION 1 0.0025
226 SINUSITIS FUNGAL 2 0.0025
227 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
228 BONE ABSCESS 1 0.0025
229 LYMPHOCYTIC LEUKAEMIA 1 0.0025
230 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21 0.0024
231 EFFUSION 3 0.0022
232 LUNG CONSOLIDATION 6 0.0021
233 ESCHERICHIA BACTERAEMIA 5 0.0021
234 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
235 BLOOD BICARBONATE INCREASED 1 0.0021
236 MINIMAL RESIDUAL DISEASE 1 0.0021
237 PANNICULITIS 5 0.0021
238 NEOPLASM RECURRENCE 7 0.0021
239 HYPERBILIRUBINAEMIA 21 0.0020
240 NECROTISING OESOPHAGITIS 1 0.0020
241 HYPERCREATININAEMIA 1 0.0020
242 CAPILLARY LEAK SYNDROME 4 0.0019
243 NON-ALCOHOLIC STEATOHEPATITIS 2 0.0019
244 TUMOUR LYSIS SYNDROME 17 0.0019
245 ACUTE MYELOID LEUKAEMIA 30 0.0019
246 BLAST CELL COUNT INCREASED 2 0.0019
247 SYSTOLIC DYSFUNCTION 2 0.0019
248 PULMONARY MUCORMYCOSIS 1 0.0019
249 HYPERMETABOLISM 1 0.0019
250 HUMAN POLYOMAVIRUS INFECTION 1 0.0019
251 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
252 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
253 INTERTRIGO 1 0.0018
254 BLOOD PH INCREASED 1 0.0018
255 NEUROLOGIC NEGLECT SYNDROME 1 0.0018
256 APNOEIC ATTACK 1 0.0018
257 CEREBRAL ISCHAEMIA 9 0.0017
258 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
259 APLASTIC ANAEMIA 9 0.0017
260 PROTRUSION TONGUE 1 0.0017
261 NECROTISING FASCIITIS 6 0.0017
262 PANCYTOPENIA 95 0.0017
263 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
264 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
265 ALVEOLAR PROTEINOSIS 1 0.0017
266 BACTERAEMIA 20 0.0017
267 CEREBRAL ASPERGILLOSIS 1 0.0016
268 MYOPATHY TOXIC 1 0.0016
269 MONOCYTOSIS 1 0.0016
270 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
271 HYPOPROTEINAEMIA 3 0.0016
272 GRANULOCYTOPENIA 9 0.0016
273 NECROTISING COLITIS 2 0.0016
274 TROPONIN T INCREASED 2 0.0016
275 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
276 ILEUS PARALYTIC 7 0.0016
277 ELECTROLYTE IMBALANCE 18 0.0015
278 PNEUMONIA NECROTISING 1 0.0015
279 PULMONARY HAEMORRHAGE 12 0.0015
280 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
281 POLYNEUROPATHY 18 0.0015
282 PNEUMOTHORAX SPONTANEOUS 1 0.0015
283 PLEURAL THICKENING 1 0.0015
284 ARACHNOIDITIS 1 0.0014
285 RASH MORBILLIFORM 4 0.0014
286 COAGULOPATHY 24 0.0014
287 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
288 FEBRILE BONE MARROW APLASIA 6 0.0014
289 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
290 MUTISM 2 0.0014
291 DIABETES MELLITUS NON-INSULIN-DEPENDENT 2 0.0014
292 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
293 LYMPHADENOPATHY 48 0.0014
294 CEREBRAL VASOCONSTRICTION 1 0.0014
295 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
296 DISSEMINATED INTRAVASCULAR COAGULATION 19 0.0013
297 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
298 BRAIN STEM SYNDROME 1 0.0013
299 ORAL HERPES 26 0.0013
300 CREATINE KINASE INCREASED 1 0.0013
301 ASPIRATION PLEURAL CAVITY 1 0.0013
302 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
303 DEVICE RELATED INFECTION 20 0.0013
304 MUCOSAL INFLAMMATION 34 0.0013
305 AGRANULOCYTOSIS 24 0.0013
306 GRIMACING 1 0.0013
307 METAPNEUMOVIRUS INFECTION 1 0.0013
308 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
309 DIARRHOEA INFECTIOUS 1 0.0013
310 HEPATOTOXICITY 28 0.0013
311 JC VIRUS INFECTION 2 0.0013
312 ACUTE LEUKAEMIA 2 0.0012
313 ENTEROCOCCAL SEPSIS 1 0.0012
314 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
315 ANAL ULCER 1 0.0012
316 CORONAVIRUS INFECTION 8 0.0012
317 CSF PROTEIN INCREASED 1 0.0012
318 QUADRIPARESIS 2 0.0012
319 FUNGAL SEPSIS 1 0.0012
320 GASTROENTERITIS SALMONELLA 1 0.0012
321 NEUTROPHIL COUNT DECREASED 49 0.0012
322 STEM CELL TRANSPLANT 3 0.0012
323 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
324 PREMATURE DELIVERY 19 0.0012
325 MYOCARDIAL FIBROSIS 1 0.0012
326 KLEBSIELLA INFECTION 6 0.0012
327 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
328 ENTERITIS INFECTIOUS 2 0.0012
329 ABDOMINAL INFECTION 3 0.0012
330 ABSCESS LIMB 5 0.0012
331 PSEUDOMONAL BACTERAEMIA 1 0.0012
332 PHYSICAL DECONDITIONING 3 0.0012
333 CORONARY ARTERY DISSECTION 1 0.0012
334 MUCORMYCOSIS 3 0.0012
335 CELLULITIS 58 0.0011
336 PULMONARY CAVITATION 1 0.0011
337 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
338 FACIAL PARESIS 4 0.0011
339 SEPTIC SHOCK 49 0.0011
340 CANDIDA SEPSIS 1 0.0011
341 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
342 EXTENSOR PLANTAR RESPONSE 1 0.0011
343 CYTOMEGALOVIRUS INFECTION 18 0.0011
344 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
345 TOOTH INFECTION 14 0.0011
346 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
347 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 18 0.0010
348 INTUSSUSCEPTION 1 0.0010
349 ILEUS 13 0.0010
350 ENTEROCOLITIS 6 0.0010
351 VOMITING PROJECTILE 3 0.0010
352 MYELODYSPLASTIC SYNDROME 15 0.0010
353 ESCHERICHIA SEPSIS 3 0.0010
354 EPIDERMAL NECROSIS 1 0.0010
355 BONE MARROW DEPRESSION 1 0.0010
356 STAPHYLOCOCCAL SEPSIS 5 0.0010
357 BLOOD CULTURE POSITIVE 3 0.0010
358 CIRCULATORY COLLAPSE 17 0.0010
359 BONE MARROW DISORDER 3 0.0010
360 POSTICTAL STATE 1 0.0010
361 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
362 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
363 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
364 ASTERIXIS 1 0.0009
365 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
366 DRUG RESISTANCE 24 0.0009
367 PSEUDOMONAS INFECTION 8 0.0009
368 BACTERIAL SEPSIS 3 0.0009
369 CYTOLYTIC HEPATITIS 3 0.0009
370 MYOCARDIAL INJURY 1 0.0009
371 KLEBSIELLA SEPSIS 1 0.0009
372 PALMAR ERYTHEMA 1 0.0009
373 HYPERTRANSAMINASAEMIA 6 0.0009
374 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
375 BILIRUBIN CONJUGATED INCREASED 2 0.0009
376 PROCALCITONIN INCREASED 1 0.0009
377 BLOOD BILIRUBIN INCREASED 23 0.0009
378 ESCHERICHIA INFECTION 7 0.0009
379 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
380 PULMONARY INFARCTION 2 0.0008
381 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
382 EMBOLISM ARTERIAL 1 0.0008
383 LYMPHADENITIS 2 0.0008
384 PHARYNGEAL INFLAMMATION 1 0.0008
385 CEREBRAL ARTERY EMBOLISM 1 0.0008
386 MONOCYTE COUNT DECREASED 1 0.0008
387 HAEMATOLOGICAL INFECTION 2 0.0008
388 ORAL MUCOSA EROSION 1 0.0008
389 LARGE INTESTINE INFECTION 1 0.0008
390 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
391 VASODILATATION 2 0.0008
392 BRAIN ABSCESS 2 0.0008
393 GLUCOSE URINE PRESENT 1 0.0008
394 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
395 CYSTITIS 25 0.0008
396 ACIDOSIS 6 0.0008
397 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
398 IATROGENIC INJURY 1 0.0008
399 ASPERGILLOSIS 1 0.0008
400 BLOOD ALBUMIN DECREASED 6 0.0008
401 OESOPHAGEAL HAEMORRHAGE 1 0.0008
402 AREFLEXIA 2 0.0007
403 CARDIOMYOPATHY 11 0.0007
404 LARGE INTESTINAL ULCER 2 0.0007
405 RECURRENT CANCER 3 0.0007
406 SUBDURAL HAEMORRHAGE 2 0.0007
407 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
408 NEOPLASM PROGRESSION 25 0.0007
409 PROCTITIS 2 0.0007
410 H1N1 INFLUENZA 1 0.0007
411 BRONCHIAL OBSTRUCTION 1 0.0007
412 COLITIS 27 0.0007
413 MUSCULOSKELETAL CHEST PAIN 11 0.0007
414 MYELITIS TRANSVERSE 1 0.0007
415 PELVIC VENOUS THROMBOSIS 1 0.0007
416 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
417 HEPATIC LESION 3 0.0007
418 RALES 4 0.0007
419 GASTROINTESTINAL NECROSIS 2 0.0007
420 TEMPERATURE INTOLERANCE 7 0.0007
421 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
422 CARDIOTOXICITY 6 0.0007
423 BRAIN HERNIATION 2 0.0007
424 PANCREATITIS ACUTE 15 0.0007
425 VASCULAR DEVICE INFECTION 3 0.0007
426 ORAL MUCOSAL EXFOLIATION 1 0.0007
427 CRANIOCEREBRAL INJURY 2 0.0007
428 ADRENAL INSUFFICIENCY 8 0.0007
429 CYTOPENIA 8 0.0007
430 DIASTOLIC DYSFUNCTION 2 0.0006
431 NEURITIS 1 0.0006
432 EJECTION FRACTION DECREASED 10 0.0006
433 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
434 MEGACOLON 1 0.0006
435 PREMATURE BABY 19 0.0006
436 INAPPROPRIATE AFFECT 1 0.0006
437 ANTICHOLINERGIC SYNDROME 1 0.0006
438 DISINHIBITION 1 0.0006
439 RESPIRATORY FAILURE 45 0.0006
440 COSTOCHONDRITIS 1 0.0006
441 PLATELET COUNT DECREASED 65 0.0006
442 HYPOGAMMAGLOBULINAEMIA 4 0.0006
443 IGA NEPHROPATHY 1 0.0006
444 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
445 EROSIVE OESOPHAGITIS 1 0.0006
446 BLOOD PH DECREASED 1 0.0006
447 NEPHROTIC SYNDROME 4 0.0006
448 ACUTE SINUSITIS 1 0.0006
449 SEPSIS 64 0.0006
450 HYPOXIA 20 0.0006
451 GASTROINTESTINAL OEDEMA 1 0.0006
452 HAEMORRHAGIC DIATHESIS 2 0.0006
453 RETINAL HAEMORRHAGE 4 0.0006
454 GRAFT VERSUS HOST DISEASE 4 0.0006
455 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
456 ALANINE AMINOTRANSFERASE INCREASED 34 0.0006
457 WHITE BLOOD CELL COUNT DECREASED 60 0.0006
458 PNEUMOMEDIASTINUM 1 0.0006
459 VENTRICULAR TACHYCARDIA 9 0.0005
460 PNEUMONIA KLEBSIELLA 1 0.0005
461 AMYLASE INCREASED 2 0.0005
462 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
463 OTOTOXICITY 1 0.0005
464 LOBAR PNEUMONIA 1 0.0005
465 CARDIAC DYSFUNCTION 2 0.0005
466 NEUTROPENIA 73 0.0005
467 HEPATIC FUNCTION ABNORMAL 20 0.0005
468 NASAL OBSTRUCTION 1 0.0005
469 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
470 PROTEIN TOTAL DECREASED 2 0.0005
471 HYPERCOAGULATION 1 0.0005
472 HYPOREFLEXIA 1 0.0005
473 OCULAR HYPERTENSION 1 0.0005
474 CARDIOPULMONARY FAILURE 2 0.0005
475 THERAPY NON-RESPONDER 23 0.0005
476 CHOLECYSTITIS 6 0.0005
477 ANORECTAL DISORDER 1 0.0005
478 DRUG INTOLERANCE 48 0.0005
479 DEVICE RELATED SEPSIS 1 0.0005
480 THROMBOCYTOPENIA 55 0.0005
481 ARTHRITIS BACTERIAL 2 0.0005
482 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
483 HYPERURICAEMIA 2 0.0005
484 GENERALISED OEDEMA 6 0.0005
485 CONGESTIVE CARDIOMYOPATHY 2 0.0005
486 SHOCK 11 0.0005
487 STOMATITIS 29 0.0005
488 LUNG ABSCESS 1 0.0005
489 LIVER DISORDER 21 0.0005
490 CD4 LYMPHOCYTES DECREASED 1 0.0005
491 MULTI-ORGAN FAILURE 8 0.0005
492 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
493 LEUKOPENIA 23 0.0005
494 HAEMOGLOBIN DECREASED 47 0.0005
495 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
496 CEREBELLAR SYNDROME 1 0.0005
497 CLOSTRIDIUM TEST POSITIVE 1 0.0005
498 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
499 PARESIS 1 0.0004
500 DRUG-INDUCED LIVER INJURY 14 0.0004
501 PAPILLOEDEMA 2 0.0004
502 DISTRIBUTIVE SHOCK 1 0.0004
503 ECCHYMOSIS 3 0.0004
504 PANCREATITIS NECROTISING 1 0.0004
505 GRAND MAL CONVULSION 4 0.0004
506 NEUROLOGICAL DECOMPENSATION 1 0.0004
507 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
508 HEPATIC ENCEPHALOPATHY 4 0.0004
509 APPENDICITIS 4 0.0004
510 SINUS TACHYCARDIA 6 0.0004
511 HAEMATOTOXICITY 4 0.0004
512 CARDIAC TAMPONADE 2 0.0004
513 METASTASIS 3 0.0004
514 NEUTROPENIC SEPSIS 3 0.0004
515 LACUNAR INFARCTION 1 0.0004
516 HYPOVOLAEMIC SHOCK 2 0.0004
517 DIABETES INSIPIDUS 1 0.0004
518 GUILLAIN-BARRE SYNDROME 2 0.0004
519 PRODUCT PACKAGING CONFUSION 1 0.0004
520 THROMBOTIC MICROANGIOPATHY 4 0.0004
521 INFECTION 59 0.0004
522 LIVER INJURY 10 0.0004
523 DERMAL CYST 1 0.0004
524 BREATH SOUNDS ABNORMAL 2 0.0004
525 ORGANISING PNEUMONIA 2 0.0004
526 HYPERNATRAEMIA 2 0.0004
527 HYPERAMMONAEMIA 2 0.0004
528 CATHETER SITE HAEMORRHAGE 1 0.0004
529 TOXIC ENCEPHALOPATHY 2 0.0004
530 APPENDICITIS PERFORATED 1 0.0004
531 LIPASE INCREASED 3 0.0004
532 HEPATOSPLENOMEGALY 1 0.0004
533 BLOOD CHLORIDE DECREASED 1 0.0004
534 LUNG INFECTION 6 0.0004
535 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
536 PULMONARY HYPERTENSION 8 0.0004
537 HEPATITIS TOXIC 1 0.0004
538 COMPARTMENT SYNDROME 1 0.0004
539 PETECHIAE 4 0.0004
540 PARTIAL SEIZURES 2 0.0004
541 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
542 LUNG OPACITY 1 0.0004
543 COMPRESSION FRACTURE 2 0.0004
544 ANAL ABSCESS 2 0.0004
545 PYREXIA 127 0.0004
546 ENCEPHALOPATHY 9 0.0004
547 ORAL FUNGAL INFECTION 1 0.0004
548 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
549 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
550 VENTRICULAR FIBRILLATION 4 0.0004
551 RASH MACULO-PAPULAR 8 0.0004
552 PULMONARY OEDEMA 16 0.0004
553 ANAL HAEMORRHAGE 1 0.0004
554 ACUTE PULMONARY OEDEMA 2 0.0004
555 FACE OEDEMA 6 0.0004
556 STATUS EPILEPTICUS 4 0.0004
557 EXPOSURE DURING PREGNANCY 22 0.0004
558 CEREBRAL THROMBOSIS 1 0.0004
559 OESOPHAGEAL STENOSIS 1 0.0004
560 NEUROLOGICAL SYMPTOM 2 0.0003
561 MYOCARDITIS 4 0.0003
562 BLOOD URIC ACID INCREASED 2 0.0003
563 PANCREATITIS 18 0.0003
564 PURPURA 3 0.0003
565 CEREBRAL HAEMORRHAGE 12 0.0003
566 ODYNOPHAGIA 2 0.0003
567 PROTHROMBIN TIME PROLONGED 2 0.0003
568 METABOLIC ENCEPHALOPATHY 1 0.0003
569 MIXED LIVER INJURY 1 0.0003
570 HEPATITIS CHOLESTATIC 2 0.0003
571 HYPERCAPNIA 1 0.0003
572 HEPATITIS B 2 0.0003
573 DYSAESTHESIA 1 0.0003
574 BRAIN DEATH 1 0.0003
575 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
576 PRODUCT USE IN UNAPPROVED INDICATION 80 0.0003
577 OLIGURIA 2 0.0003
578 HYPOCALCAEMIA 6 0.0003
579 BRAIN OEDEMA 4 0.0003
580 NON-CARDIAC CHEST PAIN 1 0.0003
581 CHOLESTASIS 6 0.0003
582 ATELECTASIS 3 0.0003
583 LIVER ABSCESS 1 0.0003
584 DEAFNESS NEUROSENSORY 1 0.0003
585 OTITIS MEDIA 1 0.0003
586 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
587 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
588 CARDIAC FAILURE ACUTE 2 0.0003
589 NEPHRITIS 1 0.0003
590 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
591 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
592 HEPATIC FAILURE 9 0.0003
593 POTENTIATING DRUG INTERACTION 1 0.0003
594 CEREBRAL HAEMATOMA 1 0.0003
595 JAUNDICE 8 0.0003
596 NEUROTOXICITY 5 0.0003
597 JAUNDICE CHOLESTATIC 1 0.0003
598 HEPATOCELLULAR INJURY 4 0.0003
599 HYPOKALAEMIA 13 0.0003
600 FIBRIN D DIMER INCREASED 1 0.0003
601 CONJUNCTIVAL HYPERAEMIA 1 0.0003
602 BONE LESION 1 0.0003
603 VISUAL FIELD DEFECT 2 0.0003
604 STAPHYLOCOCCAL INFECTION 9 0.0003
605 MOUTH HAEMORRHAGE 2 0.0003
606 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
607 HAEMORRHAGE INTRACRANIAL 4 0.0003
608 NEPHROPATHY TOXIC 3 0.0003
609 MYOCARDIAL ISCHAEMIA 3 0.0003
610 COMMUNICATION DISORDER 1 0.0003
611 PERICARDIAL EFFUSION 6 0.0003
612 EYELID OEDEMA 3 0.0003
613 ORAL INFECTION 1 0.0003
614 GASTROINTESTINAL INFLAMMATION 2 0.0003
615 RESPIRATORY DISTRESS 7 0.0003
616 MENTAL STATUS CHANGES 7 0.0003
617 HYPERLIPIDAEMIA 3 0.0003
618 CEREBRAL ATROPHY 1 0.0003
619 AZOTAEMIA 1 0.0003
620 C-REACTIVE PROTEIN INCREASED 9 0.0002
621 PNEUMONIA 80 0.0002
622 HYPERGLYCAEMIA 9 0.0002
623 BLOOD POTASSIUM INCREASED 4 0.0002
624 SHOCK HAEMORRHAGIC 2 0.0002
625 HICCUPS 2 0.0002
626 HYPERCALCAEMIA 3 0.0002
627 EMBOLISM 2 0.0002
628 GASTROINTESTINAL PERFORATION 1 0.0002
629 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
630 BLOOD UREA INCREASED 4 0.0002
631 HAEMODIALYSIS 2 0.0002
632 CARDIAC FAILURE 19 0.0002
633 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
634 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
635 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
636 OCULAR ICTERUS 1 0.0002
637 PLEURAL EFFUSION 14 0.0002
638 URINE OUTPUT DECREASED 2 0.0002
639 PARONYCHIA 1 0.0002
640 LUNG INFILTRATION 2 0.0002
641 LYMPHOCYTE COUNT DECREASED 4 0.0002
642 DRUG ERUPTION 4 0.0002
643 RESPIRATORY RATE INCREASED 2 0.0002
644 TRANSAMINASES INCREASED 5 0.0002
645 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
646 RESTLESSNESS 8 0.0002
647 PNEUMONIA BACTERIAL 2 0.0002
648 LOCALISED OEDEMA 1 0.0002
649 HEPATIC STEATOSIS 4 0.0002
650 ERYTHEMA MULTIFORME 2 0.0002
651 RENAL FAILURE ACUTE 9 0.0002
652 PULSE ABSENT 1 0.0002
653 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
654 ANAEMIA 39 0.0002
655 ASCITES 6 0.0002
656 HEPATOMEGALY 2 0.0002
657 RENAL FAILURE 27 0.0002
658 HYPERVOLAEMIA 1 0.0002
659 ABDOMINAL TENDERNESS 1 0.0002
660 DERMATITIS EXFOLIATIVE 1 0.0002
661 HYPOTENSION 40 0.0002
662 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
663 HAEMATEMESIS 5 0.0002
664 DYSLIPIDAEMIA 1 0.0002
665 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
666 AMMONIA INCREASED 1 0.0002
667 HYPOPHAGIA 5 0.0002
668 HYPONATRAEMIA 11 0.0002
669 ENDOCARDITIS 1 0.0002
670 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
671 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
672 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
673 ULCER 3 0.0002
674 NYSTAGMUS 1 0.0002
675 RASH ERYTHEMATOUS 9 0.0002
676 LACTIC ACIDOSIS 6 0.0002
677 ERYTHEMA OF EYELID 1 0.0002
678 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
679 PALLOR 5 0.0002
680 OSTEONECROSIS 6 0.0002
681 MELAENA 4 0.0002
682 NECROSIS 1 0.0002
683 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
684 INTRACRANIAL PRESSURE INCREASED 1 0.0002
685 MALNUTRITION 2 0.0002
686 PERICARDITIS 3 0.0002
687 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
688 BLOOD CALCIUM DECREASED 2 0.0002
689 CANDIDA INFECTION 3 0.0002
690 HAEMATURIA 6 0.0002
691 RED BLOOD CELL COUNT DECREASED 5 0.0002
692 HERPES VIRUS INFECTION 1 0.0002
693 LIVER FUNCTION TEST ABNORMAL 5 0.0002
694 RHINORRHOEA 11 0.0002
695 COVID-19 PNEUMONIA 2 0.0002
696 NEUROPATHY PERIPHERAL 16 0.0002
697 LOCALISED INFECTION 4 0.0002
698 PRODUCT USE ISSUE 31 0.0002
699 HAEMATOCHEZIA 9 0.0002
700 LARYNGEAL OEDEMA 1 0.0002
701 CHOLANGITIS 1 0.0002
702 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
703 BLEPHAROSPASM 1 0.0002
704 PROCTALGIA 1 0.0002
705 RASH GENERALISED 4 0.0002
706 CHOLELITHIASIS 5 0.0002
707 COGNITIVE DISORDER 7 0.0001
708 FULL BLOOD COUNT DECREASED 3 0.0001
709 FEEDING DISORDER 3 0.0001
710 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
711 PNEUMONITIS 4 0.0001
712 DRUG TOXICITY 2 0.0001
713 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
714 ACUTE HEPATIC FAILURE 2 0.0001
715 EYE MOVEMENT DISORDER 1 0.0001
716 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
717 ANAPHYLACTIC REACTION 8 0.0001
718 LARGE INTESTINE PERFORATION 1 0.0001
719 ACUTE KIDNEY INJURY 22 0.0001
720 PULMONARY TOXICITY 1 0.0001
721 CONVULSION 8 0.0001
722 SUBDURAL HAEMATOMA 2 0.0001
723 CARDIOGENIC SHOCK 2 0.0001
724 FAECES DISCOLOURED 3 0.0001
725 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
726 BLOOD CREATININE INCREASED 9 0.0001
727 FLUID OVERLOAD 2 0.0001
728 HYPOPHOSPHATAEMIA 1 0.0001
729 STEVENS-JOHNSON SYNDROME 3 0.0001
730 PULMONARY MASS 2 0.0001
731 ORAL PAIN 3 0.0001
732 HAEMODYNAMIC INSTABILITY 1 0.0001
733 HYPERTHERMIA 1 0.0001
734 RENAL IMPAIRMENT 11 0.0001
735 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
736 HAEMOLYSIS 1 0.0001
737 LYMPHOMA 2 0.0001
738 APHTHOUS ULCER 1 0.0001
739 APNOEA 1 0.0001
740 PNEUMOTHORAX 2 0.0001
741 LOW BIRTH WEIGHT BABY 1 0.0001
742 ATRIAL FLUTTER 1 0.0001
743 MOBILITY DECREASED 9 0.0001
744 DECREASED APPETITE 29 0.0001
745 OFF LABEL USE 109 0.0001
746 INTERSTITIAL LUNG DISEASE 6 0.0001
747 TACHYCARDIA 11 0.0001
748 NEURALGIA 3 0.0001
749 CARDIAC ARREST 10 0.0001
750 ACUTE CORONARY SYNDROME 1 0.0001
751 ANURIA 1 0.0001
752 MYOPATHY 1 0.0001
753 GASTRITIS 3 0.0001
754 HAEMARTHROSIS 1 0.0001
755 GASTROINTESTINAL INFECTION 1 0.0001
756 PAIN OF SKIN 3 0.0001
757 HEAVY MENSTRUAL BLEEDING 1 0.0001
758 LEUKOCYTOSIS 2 0.0001
759 INCREASED TENDENCY TO BRUISE 1 0.0001
760 DYSARTHRIA 4 0.0001
761 DYSPNOEA EXERTIONAL 4 0.0001
762 LEUKAEMIA 1 0.0001
763 AFFECT LABILITY 1 0.0001
764 SEIZURE 12 0.0001
765 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
766 ACUTE MYOCARDIAL INFARCTION 3 0.0001
767 BODY TEMPERATURE DECREASED 1 0.0001
768 HYPOTONIA 1 0.0001
769 BRAIN INJURY 1 0.0001
770 HYPERTENSION 21 0.0001
771 EMPHYSEMA 1 0.0001
772 HYPOTHERMIA 1 0.0001
773 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
774 DRY THROAT 1 0.0001
775 EPILEPSY 3 0.0001
776 NERVOUS SYSTEM DISORDER 3 0.0001
777 CARDIO-RESPIRATORY ARREST 4 0.0001
778 SKIN EXFOLIATION 8 0.0001
779 FULL BLOOD COUNT ABNORMAL 1 0.0001
780 RASH PRURITIC 5 0.0001
781 OESOPHAGITIS 1 0.0001
782 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
783 ASPIRATION 1 0.0001
784 GASTROINTESTINAL PAIN 1 0.0001
785 HYPERTENSIVE CRISIS 1 0.0001
786 INTESTINAL PERFORATION 1 0.0001
787 FISTULA 1 0.0001
788 HEPATIC ENZYME INCREASED 6 0.0001
789 CHOLECYSTECTOMY 1 0.0001
790 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
791 METASTASES TO LUNG 1 0.0001
792 DRY MOUTH 7 0.0001
793 CAESAREAN SECTION 1 0.0001
794 ATAXIA 1 0.0001
795 PRODUCTIVE COUGH 4 0.0001
796 TOXICITY TO VARIOUS AGENTS 14 0.0001
797 EMOTIONAL DISTRESS 10 0.0001
798 DRUG INTERACTION 13 0.0001
799 LUNG DISORDER 4 0.0001
800 CARDIOMEGALY 1 0.0001
801 CONDITION AGGRAVATED 24 0.0001
802 HEPATIC CYTOLYSIS 1 0.0001
803 INTRAOCULAR PRESSURE INCREASED 1 0.0001
804 HEPATITIS 2 0.0001
805 GASTROINTESTINAL DISORDER 7 0.0001
806 ANOREXIA 1 0.0001
807 HAEMATOMA 2 0.0001
808 RESPIRATORY TRACT INFECTION 2 0.0001
809 CHILLS 9 0.0001
810 IMMUNE SYSTEM DISORDER 1 0.0001
811 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
812 HYPERSENSITIVITY 14 0.0001
813 PULMONARY EMBOLISM 7 0.0001
814 OSTEOPOROSIS 3 0.0001
815 DEATH 62 0.0001
816 HYPOMAGNESAEMIA 1 0.0001
817 HAEMOPTYSIS 2 0.0001
818 CARPAL TUNNEL SYNDROME 1 0.0001
819 BLISTER 4 0.0001
820 OXYGEN SATURATION DECREASED 4 0.0001
821 DIALYSIS 1 0.0001
822 BRONCHOSPASM 1 0.0001
823 PARAESTHESIA 11 0.0001
824 HYPERHIDROSIS 9 0.0001
825 PARALYSIS 1 0.0001
826 ANGINA PECTORIS 2 0.0001
827 ABDOMINAL PAIN 16 0.0001
828 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
829 IMMUNODEFICIENCY 1 0.0001
830 ABDOMINAL DISTENSION 7 0.0001
831 RESPIRATORY DISORDER 2 0.0001
832 HYPOAESTHESIA ORAL 1 0.0001
833 THERAPEUTIC RESPONSE DECREASED 4 0.0001
834 BLOOD COUNT ABNORMAL 1 0.0001
835 DIARRHOEA 42 0.0001
836 OROPHARYNGEAL PAIN 6 0.0001
837 COMA 3 0.0001
838 HYPOTHYROIDISM 2 0.0001
839 METABOLIC ACIDOSIS 2 0.0001
840 METASTASES TO BONE 1 0.0001
841 HEART RATE INCREASED 6 0.0001
842 PHOTOSENSITIVITY REACTION 1 0.0001
843 INFUSION RELATED REACTION 4 0.0001
844 PALPITATIONS 7 0.0001
845 VOMITING 28 0.0001
846 TYPE 2 DIABETES MELLITUS 2 0.0001
847 DISEASE PROGRESSION 7 0.0001
848 HEMIPARESIS 1 0.0001
849 FLUID RETENTION 3 0.0001
850 MYALGIA 10 0.0001
851 LOCAL SWELLING 1 0.0001
852 AMENORRHOEA 1 0.0001
853 METASTASES TO LIVER 1 0.0001
854 DEPRESSED MOOD 3 0.0001
855 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
856 CONSTIPATION 12 0.0001
857 CONJUNCTIVITIS 1 0.0001
858 INFLUENZA 6 0.0001
859 MIDDLE INSOMNIA 1 0.0001
860 PHOTOPHOBIA 1 0.0001
861 BLOOD URINE PRESENT 1 0.0001
862 GASTRIC ULCER 1 0.0001
863 PROTEINURIA 1 0.0001
864 DIABETES MELLITUS 4 0.0001
865 PULMONARY FIBROSIS 1 0.0001
866 ACUTE RESPIRATORY FAILURE 1 0.0001
867 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
868 HAEMORRHOIDS 1 0.0001
869 CHOKING 1 0.0001
870 MENORRHAGIA 1 0.0001
871 ASTHENIA 19 0.0001
872 HAEMATOCRIT DECREASED 1 0.0001
873 PRESCRIBED UNDERDOSE 1 0.0001
874 IRRITABILITY 3 0.0000
875 CYTOKINE RELEASE SYNDROME 1 0.0000
876 OEDEMA PERIPHERAL 6 0.0000
877 VERTIGO 3 0.0000
878 RHABDOMYOLYSIS 2 0.0000
879 MOUTH ULCERATION 1 0.0000
880 HALLUCINATION, VISUAL 1 0.0000
881 BACK PAIN 11 0.0000
882 EATING DISORDER 1 0.0000
883 NAUSEA 37 0.0000
884 LIVER FUNCTION TEST INCREASED 1 0.0000
885 VAGINAL HAEMORRHAGE 2 0.0000
886 RASH 20 0.0000
887 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
888 CHROMATURIA 1 0.0000
889 MUSCULAR WEAKNESS 5 0.0000
890 RENAL DISORDER 2 0.0000
891 BLOOD CHOLESTEROL INCREASED 2 0.0000
892 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
893 CARDIAC DISORDER 4 0.0000
894 ARRHYTHMIA 2 0.0000
895 OCULAR HYPERAEMIA 2 0.0000
896 DYSPHAGIA 4 0.0000
897 DISEASE RECURRENCE 2 0.0000
898 EPISTAXIS 3 0.0000
899 DRY EYE 2 0.0000
900 PNEUMONIA ASPIRATION 1 0.0000
901 WEIGHT DECREASED 11 0.0000
902 CARDIOVASCULAR DISORDER 1 0.0000
903 FLUSHING 4 0.0000
904 ERYTHEMA 8 0.0000
905 ANAPHYLACTIC SHOCK 1 0.0000
906 INFLAMMATION 2 0.0000
907 DEAFNESS 1 0.0000
908 MUSCULOSKELETAL PAIN 2 0.0000
909 TREATMENT NONCOMPLIANCE 2 0.0000
910 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
911 TREATMENT FAILURE 3 0.0000
912 MEDICATION ERROR 2 0.0000
913 COUGH 10 0.0000
914 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
915 HYPERSOMNIA 1 0.0000
916 LETHARGY 2 0.0000
917 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
918 COVID-19 6 0.0000
919 PSYCHOTIC DISORDER 1 0.0000
920 BLOOD POTASSIUM DECREASED 1 0.0000
921 APHASIA 1 0.0000
922 DRUG INEFFECTIVE 43 0.0000
923 GYNAECOMASTIA 1 0.0000
924 VISUAL IMPAIRMENT 4 0.0000
925 DYSPNOEA 18 0.0000
926 HEAD INJURY 1 0.0000
927 CONTUSION 3 0.0000
928 HEADACHE 19 0.0000
929 TREMOR 5 0.0000
930 BLOOD PRESSURE DECREASED 2 0.0000
931 INSOMNIA 8 0.0000
932 SINUSITIS 3 0.0000
933 DELIRIUM 1 0.0000
934 HAEMORRHAGE 3 0.0000
935 HYPERKALAEMIA 1 0.0000
936 HEART RATE DECREASED 1 0.0000
937 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
938 BRONCHITIS 2 0.0000
939 INTESTINAL OBSTRUCTION 1 0.0000
940 DIZZINESS 13 0.0000
941 PRURITUS 10 0.0000
942 ABNORMAL BEHAVIOUR 1 0.0000
943 ABORTION SPONTANEOUS 1 0.0000
944 CARDIAC FAILURE CONGESTIVE 2 0.0000
945 SOMNOLENCE 5 0.0000
946 DYSKINESIA 1 0.0000
947 CEREBROVASCULAR ACCIDENT 4 0.0000
948 URINARY TRACT INFECTION 4 0.0000
949 LOSS OF CONSCIOUSNESS 3 0.0000
950 MENTAL DISORDER 1 0.0000
951 DEHYDRATION 3 0.0000
952 NEPHROLITHIASIS 1 0.0000
953 HYPOGLYCAEMIA 1 0.0000
954 SYNCOPE 2 0.0000
955 DISTURBANCE IN ATTENTION 1 0.0000
956 OEDEMA 1 0.0000
957 NECK PAIN 1 0.0000
958 FLATULENCE 1 0.0000
959 HERPES ZOSTER 1 0.0000
960 PAIN IN EXTREMITY 5 0.0000
961 NO ADVERSE EVENT 3 0.0000
962 DISCOMFORT 1 0.0000
963 DEEP VEIN THROMBOSIS 1 0.0000
964 ALOPECIA 3 0.0000
965 NEOPLASM MALIGNANT 1 0.0000
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
967 AGITATION 1 0.0000
968 BLOOD PRESSURE INCREASED 2 0.0000
969 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
970 ABDOMINAL DISCOMFORT 2 0.0000
971 BALANCE DISORDER 1 0.0000
972 CHEST PAIN 2 0.0000
973 ATRIAL FIBRILLATION 1 0.0000
974 PAIN 6 0.0000
975 CHEST DISCOMFORT 1 0.0000
976 ASTHMA 1 0.0000
977 JOINT SWELLING 1 0.0000
978 FATIGUE 6 0.0000
979 DRY SKIN 1 0.0000
980 MEMORY IMPAIRMENT 1 0.0000
981 ARTHRALGIA 3 0.0000
982 HYPOAESTHESIA 1 0.0000
983 HOSPITALISATION 1 0.0000
984 CONFUSIONAL STATE 1 0.0000
985 FALL 2 0.0000
986 MUSCLE SPASMS 1 0.0000
987 NASOPHARYNGITIS 1 0.0000
988 BLOOD GLUCOSE INCREASED 1 0.0000
989 GAIT DISTURBANCE 1 0.0000
990 ABDOMINAL PAIN UPPER 1 0.0000
991 OVERDOSE 1 0.0000
992 INJECTION SITE PAIN 1 0.0000
993 MALAISE 1 0.0000